Package 0069-0486-03

Brand: ibrance

Generic: palbociclib
NDC Package

Package Facts

Identity

Package NDC 0069-0486-03
Digits Only 0069048603
Product NDC 0069-0486
Product ID 0069-0486_01800bda-3788-40c5-976b-c054dda1c0b2
Description

3 DOSE PACK in 1 CARTON (0069-0486-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0486-07)

Marketing

Marketing Status
Marketed Since 2020-03-30
Brand ibrance
Generic palbociclib
Sample Package No

Linked Drug Pages (1)

Ibrance ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01800bda-3788-40c5-976b-c054dda1c0b2", "openfda": {"nui": ["N0000175605", "N0000175082", "N0000190114"], "unii": ["G9ZF61LE7G"], "rxcui": ["2284102", "2284104", "2284105", "2284106", "2284107", "2284108"], "spl_set_id": ["fecbdd7d-b729-41b5-9872-231b8fe104ce"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Kinase Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 DOSE PACK in 1 CARTON (0069-0486-03)  / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0486-07)", "package_ndc": "0069-0486-03", "marketing_start_date": "20200330"}], "brand_name": "Ibrance", "product_id": "0069-0486_01800bda-3788-40c5-976b-c054dda1c0b2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Kinase Inhibitors [MoA]"], "product_ndc": "0069-0486", "generic_name": "palbociclib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ibrance", "active_ingredients": [{"name": "PALBOCICLIB", "strength": "100 mg/1"}], "application_number": "NDA212436", "marketing_category": "NDA", "marketing_start_date": "20200330", "listing_expiration_date": "20271231"}